BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 25645675)

  • 41. Prostaglandin E2 promotes the cell growth and invasive ability of hepatocellular carcinoma cells by upregulating c-Myc expression via EP4 receptor and the PKA signaling pathway.
    Xia S; Ma J; Bai X; Zhang H; Cheng S; Zhang M; Zhang L; Du M; Wang Y; Li H; Rong R; Shi F; Yang Q; Leng J
    Oncol Rep; 2014 Oct; 32(4):1521-30. PubMed ID: 25109834
    [TBL] [Abstract][Full Text] [Related]  

  • 42. PGE
    Gonzalez AA; Salinas-Parra N; Leach D; Navar LG; Prieto MC
    Am J Physiol Renal Physiol; 2017 Oct; 313(4):F1038-F1049. PubMed ID: 28701311
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cell type specificity of PI3K signaling in Pdk1- and Pten-deficient brains.
    Chalhoub N; Zhu G; Zhu X; Baker SJ
    Genes Dev; 2009 Jul; 23(14):1619-24. PubMed ID: 19605683
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Characterization of the EP receptor subtype that mediates the inhibitory effects of prostaglandin E2 on IgE-dependent secretion from human lung mast cells.
    Kay LJ; Gilbert M; Pullen N; Skerratt S; Farrington J; Seward EP; Peachell PT
    Clin Exp Allergy; 2013 Jul; 43(7):741-51. PubMed ID: 23786281
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cardioprotective stimuli mediate phosphoinositide 3-kinase and phosphoinositide dependent kinase 1 nuclear accumulation in cardiomyocytes.
    Rubio M; Avitabile D; Fischer K; Emmanuel G; Gude N; Miyamoto S; Mishra S; Schaefer EM; Brown JH; Sussman MA
    J Mol Cell Cardiol; 2009 Jul; 47(1):96-103. PubMed ID: 19269295
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Myosin 5b loss of function leads to defects in polarized signaling: implication for microvillus inclusion disease pathogenesis and treatment.
    Kravtsov D; Mashukova A; Forteza R; Rodriguez MM; Ameen NA; Salas PJ
    Am J Physiol Gastrointest Liver Physiol; 2014 Nov; 307(10):G992-G1001. PubMed ID: 25258405
    [TBL] [Abstract][Full Text] [Related]  

  • 47. PDK1 inhibitor GSK2334470 exerts antitumor activity in multiple myeloma and forms a novel multitargeted combination with dual mTORC1/C2 inhibitor PP242.
    Yang C; Huang X; Liu H; Xiao F; Wei J; You L; Qian W
    Oncotarget; 2017 Jun; 8(24):39185-39197. PubMed ID: 28402933
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Differential dependence of eosinophil chemotactic responses on phosphoinositide 3-kinase (PI3K).
    Mishra RK; Scaife JE; Harb Z; Gray BC; Djukanovic R; Dent G
    Allergy; 2005 Sep; 60(9):1204-7. PubMed ID: 16076309
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Small-molecule inhibitors of PDK1.
    Peifer C; Alessi DR
    ChemMedChem; 2008 Dec; 3(12):1810-38. PubMed ID: 18972468
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Prostaglandin E
    Zhou Y; Wang W; Zhao C; Wang Y; Wu H; Sun X; Guan Y; Zhang Y
    Front Immunol; 2018; 9():501. PubMed ID: 29593738
    [TBL] [Abstract][Full Text] [Related]  

  • 51. T11TS immunotherapy repairs PI3K-AKT signaling in T-cells: Clues toward enhanced T-cell survival in rat glioma model.
    Chaudhuri S; Singh MK; Bhattacharya D; Datta A; Hazra I; Mondal S; Faruk Sk Md O; Ronsard L; Ghosh TK; Chaudhuri S
    J Cell Physiol; 2018 Feb; 233(2):759-770. PubMed ID: 28608562
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Decreased MAPK- and PGE2-dependent IL-11 production in Gialpha2-/- colonic myofibroblasts.
    Hoang B; Trinh A; Birnbaumer L; Edwards RA
    Am J Physiol Gastrointest Liver Physiol; 2007 Jun; 292(6):G1511-9. PubMed ID: 17332478
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Prostaglandin E2 Reduces Cardiac Contractility via EP3 Receptor.
    Gu X; Xu J; Zhu L; Bryson T; Yang XP; Peterson E; Harding P
    Circ Heart Fail; 2016 Aug; 9(8):. PubMed ID: 27502370
    [TBL] [Abstract][Full Text] [Related]  

  • 54. PDK1-AKT signaling pathway regulates the expression and function of cardiac hyperpolarization-activated cyclic nucleotide-modulated channels.
    Han Z; Wu X; Gao Y; Liu X; Bai J; Gu R; Lan R; Xu B; Xu W
    Life Sci; 2020 Jun; 250():117546. PubMed ID: 32184125
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Characterization of PGE2 receptor subtypes in human eosinophils.
    Mita H; Hasegawa M; Higashi N; Akiyama K
    J Allergy Clin Immunol; 2002 Sep; 110(3):457-9. PubMed ID: 12209094
    [TBL] [Abstract][Full Text] [Related]  

  • 56. PGE2 inhibits MMP expression by suppressing MKK4-JNK MAP kinase-c-JUN pathway via EP4 in human articular chondrocytes.
    Nishitani K; Ito H; Hiramitsu T; Tsutsumi R; Tanida S; Kitaori T; Yoshitomi H; Kobayashi M; Nakamura T
    J Cell Biochem; 2010 Feb; 109(2):425-33. PubMed ID: 19998410
    [TBL] [Abstract][Full Text] [Related]  

  • 57. PPARĪ³ as an E3 Ubiquitin-Ligase Impedes Phosphate-Stat6 Stability and Promotes Prostaglandins E
    Wu J; Wang Y; Zhou Y; Wang Y; Sun X; Zhao Y; Guan Y; Zhang Y; Wang W
    Front Immunol; 2020; 11():1224. PubMed ID: 32636842
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cooperativity of E-prostanoid receptor subtypes in regulating signaling and growth inhibition in human airway smooth muscle.
    Michael JV; Gavrila A; Nayak AP; Pera T; Liberato JR; Polischak SR; Shah SD; Deshpande DA; Penn RB
    FASEB J; 2019 Apr; 33(4):4780-4789. PubMed ID: 30601680
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Opposing effects of prostaglandin E
    Carboneau BA; Allan JA; Townsend SE; Kimple ME; Breyer RM; Gannon M
    Mol Metab; 2017 Jun; 6(6):548-559. PubMed ID: 28580285
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Dissociation between the translocation and the activation of Akt in fMLP-stimulated human neutrophils--effect of prostaglandin E2.
    Burelout C; Naccache PH; Bourgoin SG
    J Leukoc Biol; 2007 Jun; 81(6):1523-34. PubMed ID: 17339610
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.